AXL, Akt2 and follicle-stimulating hormone (FSH) directly target the expression of PKM2, thereby promoting aerobic glycolysis to stimulate proliferation, invasion, migration and cisplatin resistance in ovarian cancer cells 68, 95-97. The gene discussed is PKM; the disease is ovarian carcinoma.